BACKGROUND: Microsurgical circumferential stripping of intracerebral metastases is often insufficient in achieving local tumor control. Supramarginal resection may improve local tumor control. METHODS: A retrospective analysis was performed for patients who underwent supramarginal resection of a cerebral metastasis by awake surgery with intraoperative cortical and subcortical stimulation, MEPs, and SSEPs. Supramarginal resection was achieved by circumferential stripping of the metastasis and additional removal of approximately 3 mm of the surrounding tissue. Pre- and postsurgical neurological status was assessed by the NIH Stroke Scale. Permanent deficits were defined by persistence after 3-month observation time. RESULTS: Supramarginal resection of cerebral metastases in eloquent brain areas was performed in 34 patients with a mean age of 60 years (range, 33-83 years). Five out of 34 patients (14.7%) had a new transient postoperative neurological deficit, which improved within a few days due to supplementary motor area (SMA) syndrome. Five out of 34 patients (14.7%) developed a local in-brain progression and nine patients (26.4%) a distant in-brain progression. CONCLUSIONS: Supramarginal resection of cerebral metastases in eloquent locations is feasible and safe. Safety might be increased by intraoperative neuromonitoring. The better outcome in the present series may be entirely based on other predictors than extend of surgical resection and not necessarily on the surgical technique applied. However, supramarginal resection was safe and apparently did not lead to worse results than regular surgical techniques. Prospective, controlled, and randomized studies are mandatory to determine the possible benefit of supramarginal resection on local tumor control and overall outcome.
BACKGROUND: Microsurgical circumferential stripping of intracerebral metastases is often insufficient in achieving local tumor control. Supramarginal resection may improve local tumor control. METHODS: A retrospective analysis was performed for patients who underwent supramarginal resection of a cerebral metastasis by awake surgery with intraoperative cortical and subcortical stimulation, MEPs, and SSEPs. Supramarginal resection was achieved by circumferential stripping of the metastasis and additional removal of approximately 3 mm of the surrounding tissue. Pre- and postsurgical neurological status was assessed by the NIH Stroke Scale. Permanent deficits were defined by persistence after 3-month observation time. RESULTS: Supramarginal resection of cerebral metastases in eloquent brain areas was performed in 34 patients with a mean age of 60 years (range, 33-83 years). Five out of 34 patients (14.7%) had a new transient postoperative neurological deficit, which improved within a few days due to supplementary motor area (SMA) syndrome. Five out of 34 patients (14.7%) developed a local in-brain progression and nine patients (26.4%) a distant in-brain progression. CONCLUSIONS: Supramarginal resection of cerebral metastases in eloquent locations is feasible and safe. Safety might be increased by intraoperative neuromonitoring. The better outcome in the present series may be entirely based on other predictors than extend of surgical resection and not necessarily on the surgical technique applied. However, supramarginal resection was safe and apparently did not lead to worse results than regular surgical techniques. Prospective, controlled, and randomized studies are mandatory to determine the possible benefit of supramarginal resection on local tumor control and overall outcome.
Authors: Marcel A Kamp; Philipp J Slotty; Jan F Cornelius; Hans-Jakob Steiger; Marion Rapp; Michael Sabel Journal: Neurosurg Rev Date: 2016-07-09 Impact factor: 3.042
Authors: Peter Baumgarten; Johanna Quick-Weller; Florian Gessler; Marlies Wagner; Julia Tichy; Marie-Therese Forster; Christian Foerch; Volker Seifert; Michel Mittelbronn; Christian Senft Journal: J Neurooncol Date: 2018-05-24 Impact factor: 4.130
Authors: Johannes Knipps; Igor Fischer; Lisa M Neumann; Marion Rapp; Maxine Dibué-Adjei; Christiane Freiin von Saß; Jan-Malte Placke; Hendrik-Jan Mijderwijk; Hans-Jakob Steiger; Michael Sabel; Jan-Frederick Cornelius; Marcel A Kamp Journal: Clin Exp Metastasis Date: 2019-08-02 Impact factor: 5.150
Authors: Sherise D Ferguson; Kathryn M Wagner; Sujit S Prabhu; Mary F McAleer; Ian E McCutcheon; Raymond Sawaya Journal: Clin Exp Metastasis Date: 2017-09-30 Impact factor: 5.150
Authors: Rasheed Zakaria; Angela Platt-Higgins; Nitika Rathi; Mark Radon; Sumit Das; Kumar Das; Maneesh Bhojak; Andrew Brodbelt; Emmanuel Chavredakis; Michael D Jenkinson; Philip S Rudland Journal: Cancer Res Date: 2017-12-06 Impact factor: 12.701
Authors: Federico Pessina; Pierina Navarria; Luca Cozzi; Anna Maria Ascolese; Giulia Maggi; Marco Riva; Giovanna Masci; Giuseppe D'Agostino; Giovanna Finocchiaro; Armando Santoro; Lorenzo Bello; Marta Scorsetti Journal: PLoS One Date: 2016-06-27 Impact factor: 3.240
Authors: Marcel A Kamp; Igor Fischer; Julia Bühner; Bernd Turowski; Jan Frederick Cornelius; Hans-Jakob Steiger; Marion Rapp; Philipp J Slotty; Michael Sabel Journal: Oncotarget Date: 2016-10-11